Výsledky vyhledávání - "Herrington, KA"

Spatial analysis of Cdc42 activity reveals a role for plasma membrane-associated Cdc42 in centrosome regulation

Autor: Herrington, KA, Trinh, AL, Dang, C, O'Shaughnessy, E, Hahn, KM, Gratton, E, Digman, MA, Sutterlin, C

Publikováno v: Herrington, KA; Trinh, AL; Dang, C; O'Shaughnessy, E; Hahn, KM; Gratton, E; et al.(2017). Spatial analysis of Cdc42 activity reveals a role for plasma membrane-associated Cdc42 in centrosome regulation. MOLECULAR BIOLOGY OF THE CELL, 28(15), 2135-2145. doi: 10.1091/mbc.E16-09-0665. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3312g1zc

The ability of the small GTPase Cdc42 to regulate diverse cellular processes depends on tight spatial control of its activity. Cdc42 function is best understood at the plasma membrane (PM), where it regulates cytoskeletal organization and cell polari

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::e4330079a40917442946ea1878cc9a27
http://www.escholarship.org/uc/item/3312g1zc

Zobrazit plný text záznamu

Dissertation/ Thesis

Towards a closer investigation of the planner's agency at the micro-practice of planning

Autor: Herrington, Katie

The research examines, at the micro level of the individual planner during their 'mundane' day to day practice, what is structuring their behaviour, within the particular context of speed performance. Drawing upon the observations that planners are r

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729363

Zobrazit plný text záznamu

Akademický článek

mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes.

Autor: Leng K; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.; Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu., Rooney B; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA., McCarthy F; Chan Zuckerberg Biohub, San Francisco, CA, USA., Xia W; Departments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA., Rose IVL; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Bax S; Chan Zuckerberg Biohub, San Francisco, CA, USA., Chin M; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Fathi S; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA., Herrington KA; Center for Advanced Microscopy, University of California, San Francisco, San Francisco, CA, USA., Leonetti M; Chan Zuckerberg Biohub, San Francisco, CA, USA., Kao A; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Fancy SPJ; Departments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA., Elias JE; Chan Zuckerberg Biohub, San Francisco, CA, USA., Kampmann M; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.

Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2024 Aug 08; Vol. 21 (1), pp. 198. Date of Electronic Publication: 2024 Aug 08.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.

Autor: Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Chou YT; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Fernández-Méndez C; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Yu J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Meraz IM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barbosa Rabago D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Allegakoen DV; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Guan J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA., Shah KN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Herrington KA; Center for Advanced Light Microscopy, University of California, San Francisco, San Francisco, CA, USA., Gbenedio OM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Nanjo S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan., Majidi M; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Pourmoghadam YK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McCoach CE; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gutkind JS; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA., Tang TT; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Post L; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA., Huang B; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Santisteban P; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Goodarzi H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA., Bandyopadhyay S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA., Kuo CJ; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Roose JP; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.

Publikováno v: Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3741. Date of Electronic Publication: 2024 May 03.

Zobrazit plný text záznamu

Akademický článek

A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.

Autor: Swaney DL; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Ramms DJ; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA., Wang Z; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA., Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA., Goto Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA., Soucheray M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Bhola N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Kim K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA., Zeng Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., McGregor M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California San Francisco, San Francisco, CA, USA., O'Keefe R; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Jin N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., VanLandingham NK; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Foussard H; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Von Dollen J; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Bouhaddou M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Jimenez-Morales D; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Obernier K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA., Kim M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA., Johnson DE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Jura N; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Grandis JR; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Gutkind JS; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA., Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Department of Computer Science, University of California San Diego, La Jolla, CA, USA., Krogan NJ; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.

Publikováno v: Science (New York, N.Y.) [Science] 2021 Oct; Vol. 374 (6563), pp. eabf2911. Date of Electronic Publication: 2021 Oct 01.

Zobrazit plný text záznamu

Akademický článek

Interpretation of cancer mutations using a multiscale map of protein systems.

Autor: Zheng F; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Kelly MR; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Ramms DJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA., Heintschel ML; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA., Tao K; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA., Tutuncuoglu B; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA., Lee JJ; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Ono K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Foussard H; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA., Chen M; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California, San Francisco, CA 94158, USA., Silva E; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Liu SN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Chen J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Churas C; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Wilson N; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Kratz A; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Pillich RT; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Patel DN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Park J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Kuenzi B; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Yu MK; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Licon K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Pratt D; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA., Kreisberg JF; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA., Kim M; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA., Swaney DL; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA., Nan X; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA.; Knight Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, OR 97201, USA., Fraley SI; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA., Gutkind JS; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA., Krogan NJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA., Ideker T; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2021 Oct; Vol. 374 (6563), pp. eabf3067. Date of Electronic Publication: 2021 Oct 01.

Zobrazit plný text záznamu

Akademický článek

A protein interaction landscape of breast cancer.

Autor: Kim M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA., Bouhaddou M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Kim K; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Rojc A; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Modak M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Soucheray M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., McGregor MJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., O'Leary P; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Wolf D; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Stevenson E; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Foo TK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Mitchell D; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA., Herrington KA; Department of Biochemistry and Biophysics, Center for Advanced Light Microscopy, University of California, San Francisco, CA, USA., Muñoz DP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Tutuncuoglu B; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Chen KH; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA., Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA., Diolaiti ME; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Gordan JD; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA., Coppé JP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Swaney DL; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA., Xia B; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., van 't Veer L; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Ashworth A; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Department of Bioengineering, University of California, San Diego, CA, USA., Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2021 Oct; Vol. 374 (6563), pp. eabf3066. Date of Electronic Publication: 2021 Oct 01.

Zobrazit plný text záznamu

Akademický článek

Spatial analysis of Cdc42 activity reveals a role for plasma membrane-associated Cdc42 in centrosome regulation.

Autor: Herrington KA; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697., Trinh AL; Department of Biomedical Engineering, University of California, Irvine, Irvine, CA 92697., Dang C; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697., O'Shaughnessy E; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Hahn KM; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Gratton E; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697.; Department of Biomedical Engineering, University of California, Irvine, Irvine, CA 92697.; Centre for Bioactive Discovery in Health and Ageing, School of Science and Technology, University of New England, Armidale, NSW 2351, Australia., Digman MA; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697.; Department of Biomedical Engineering, University of California, Irvine, Irvine, CA 92697.; Centre for Bioactive Discovery in Health and Ageing, School of Science and Technology, University of New England, Armidale, NSW 2351, Australia., Sütterlin C; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697 suetterc@uci.edu.

Publikováno v: Molecular biology of the cell [Mol Biol Cell] 2017 Jul 15; Vol. 28 (15), pp. 2135-2145. Date of Electronic Publication: 2017 May 24.

Zobrazit plný text záznamu